EX-99.1 3 v154559_ex99-1.htm EX-99.1
Exhibit 99.2

UNAUDITED PRO FORMA COMBINED CONDENSED FINANCIAL INFORMATION
 
On May 4, 2009, ZOLL Medical Corporation (the “Company” or “ZOLL”) completed the acquisition of substantially all the assets of the intravascular temperature management business of Alsius Corporation (“Alsius”) pursuant to an Asset Purchase Agreement (the “Agreement”) by and among ZOLL Circulation, Inc., a wholly-owned subsidiary of the Company, Alsius and Alsius Medical Corporation, dated February 19, 2009. The assets acquired include intellectual property and other intangibles related to the business, inventories and fixed assets. The Company will also assume warranty and service contract obligations relating to Alsius’ installed base of products. The Company paid approximately $12 million in cash as consideration for the assets. The Company also has paid approximately $0.2 million related to acquisition costs.

The following unaudited pro forma combined condensed financial statements give effect to the acquisition of substantially all the assets of the intravascular temperature management business of Alsius by the Company.

The unaudited pro forma combined condensed statements of operations for the twelve months ended September 28, 2008 and three months ended December 28, 2008, give effect to the acquisition as if it had occurred on October 1, 2007.  The unaudited pro forma combined condensed statement of operations for the twelve months ended September 28, 2008 includes amounts derived from the audited consolidated statement of income of ZOLL for the year ended September 28, 2008, and the unaudited statement of operations of Alsius for the twelve months ended September 30, 2008, and pro forma adjustments to reflect the Alsius asset acquisition.  Alsius’ historical statement of operations has been conformed to ZOLL’s fiscal year. Alsius had a fiscal year ending on December 31.

The unaudited pro forma combined condensed balance sheet as of December 28, 2008 gives effect to the asset acquisition as if it had occurred on December 28, 2008.  This balance sheet includes the unaudited consolidated balance sheet of ZOLL as of December 28, 2008, the audited balance sheet of Alsius as of December 31, 2008, and pro forma adjustments to reflect the asset acquisition.

The unaudited pro forma combined condensed financial statements should be read in conjunction with the historical consolidated financial statements of Alsius, which are incorporated by reference into this report, and the consolidated financial statements and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of ZOLL included in its Annual Report on Form 10-K for the year ended September 28, 2008.  The unaudited pro forma combined condensed financial statements are not necessarily indicative of the financial position that would have been obtained or the financial results that would have occurred if the Alsius asset acquisition had been consummated on the dates indicated, nor are they necessarily indicative of the financial position or financial results which may be attained in the future, including synergies that may be achieved. The unaudited pro forma combined condensed financial statements do not reflect the realization of potential cost savings. No assurances can be made that ZOLL will realize efficiencies related to the integration of the businesses sufficient to offset incremental transaction and integration costs over time. Cost savings, if achieved, could result from, among other things, the reduction of overhead expenses and leveraging of ZOLL’s existing infrastructure.
 
Page 1 of 6

 
Exhibit 99.2
 
The pro forma adjustments, as described in the “Notes to Pro Forma Combined Condensed Financial Statements,” are based upon available information and upon certain assumptions that ZOLL’s management believes are reasonable.  The Alsius asset acquisition is being accounted for using the purchase method of accounting under SFAS 141, “Business Combinations”.  The allocation of the purchase price is preliminary.  Final amounts could differ from those reflected in the pro forma combined condensed financial statements, and such differences could be significant.  Upon final determination, the purchase price will be allocated to the assets and liabilities acquired based on fair value as of the date of the acquisition.

The following is a summary of the Company’s preliminary estimate of the fair values of the assets acquired and liabilities assumed. On a preliminary basis, for purposes of the accompanying unaudited pro forma condensed combined balance sheet, the purchase price was allocated based on the December 31, 2008 balance sheet of Alsius as follows:

(in thousands)
 
Unaudited
 
Assets:
     
Current assets
  $ 27  
Inventory
    5,935  
Property and equipment
    1,679  
Goodwill
    1,281  
Other intangibles
    3,500  
Total assets acquired
    12,422  
         
Liabilities:
       
Current liabilities
    198  
Total liabilities assumed
    198  
         
Net assets acquired
  $ 12,224  

The fair value of certain identifiable intangible assets are based upon preliminary estimates and are subject to change which could be material. The following are preliminary intangible assets acquired and their respective amortizable lives:

   
Amount
   
Amortizable
life (years)
 
Asset
           
Customer Relationships
  $ 1,000       10  
Acquired technology
    2,000       10  
Tradenames
    500       8  
    $ 3,500          
 
Page 2 of 6

 
Exhibit 99.2
 
Unaudited Pro Forma Combined Balance Sheet
December 28, 2008
(in thousands)

   
ZOLL
   
Alsius
   
Adjustments
     
Total
 
Assets
                         
Current assets:
                         
Cash and cash equivalents
  $ 43,552     $ 5,605     $ (5,605 ) (B)   $ 31,328  
                      (12,224 ) (A)        
Marketable securities
    22,391                         22,391  
Accounts receivable
    77,637       2,958       (2,958 ) (B)     77,637  
Inventories
    62,388       5,810       125   (F)     68,323  
Prepaid expenses and other current assets
    12,484       388       (361 ) (B)     12,511  
Total current assets
    218,452       14,761       (21,023 )       212,190  
                                   
Net property and equipment
    35,156       2,101       (422 ) (B)     36,835  
                                   
Investments
    1,310                         1,310  
Notes receivable
    3,048                         3,048  
Long-term marketable securities
    1,604                         1,604  
Goodwill
    41,811               1,281   (C)     43,092  
Patents and developed technology, net
    20,515                         20,515  
Intangibles and other assets, net
    17,563       212       (212 ) (B)     21,063  
                      3,500   (D)        
    $ 339,459     $ 17,074     $ (16,876 )     $ 339,657  
Liabilities and Stockholders’ Equity
                                 
Current liabilities:
                                 
Accounts payable
  $ 19,109     $ 2,113     $ (2,113 ) (B)   $ 19,109  
Deferred revenue
    26,435                         26,435  
Accrued exp. and other liabilities
    22,017       1,724       (1,724 ) (B)     22,215  
                      198   (E)        
Current portion of long-term debt
            3,216       (3,216 ) (B)        
Current portion of capital lease obligations
            27       (27 ) (B)        
Total current liabilities
    67,561       7,080       (6,882 )       67,759  
                                   
Other long-term liabilities
    2,921       626       (626 ) (B)     2,921  
                                   
Stockholders’ Equity:
                                 
                                   
Common stock
    210       2       (2 ) (H)     210  
Capital in excess of par
    156,407       126,233       (126,233 ) (H)     156,407  
Accumulated other comprehensive loss
    (10,228 )             -         (10,228 )
Retained earnings
    122,588       (116,867 )     116,867   (H)     122,588  
Total stockholders’ equity
    268,977       9,368       (9,368 )       268,977  
    $ 339,459     $ 17,074     $ (16,876 )     $ 339,657  

 
Page 3 of 6

 
 
Exhibit 99.2
  
Unaudited Pro Forma Combined Condensed Statement of Operations
For the Three Months Ended December 28, 2008
(in thousands except per share data)

   
ZOLL
   
Alsius
   
Adjustment
     
Total
 
                           
Net sales
  $ 89,462     $ 3,840             $ 93,302  
Cost of goods sold
    42,549       2,539               45,088  
Gross profit
    46,913       1,301               48,214  
                                 
Expenses:
                               
Selling and marketing
    26,549       2,932               29,481  
General and administrative
    7,633       927     $ 50   (J)     8,610  
Research and development
    7,969       879                 8,848  
Total expenses
    42,151       4,738       50         46,939  
                                   
Income (loss) from operations
    4,762       (3,437 )     (50 )       1,275  
                                   
Investment and other income (expense)
    (869 )     (110 )     110   (G)     (869 )
                                   
Income (loss) before income taxes
    3,893       (3,547 )     60         406  
                                   
Provision (benefit) for income taxes
    999               (1,220 ) (I)     (221 )
                                   
Net income (loss)
  $ 2,894     $ (3,547 )   $ 1,280       $ 627  
                                   
Basic earnings per common share
  $ 0.14                       $ 0.03  
Weighted average common shares outstanding
    21,061                         21,061  
Diluted earnings per common and common equivalent share
  $ 0.14                       $ 0.03  
Weighted average common and common equivalent shares outstanding
    21,304                         21,304  
 
Page 4 of 6

 
Exhibit 99.2
 
Unaudited Pro Forma Combined Condensed Statement of Operations
For the Twelve Months Ended September 28, 2008
(in thousands except per share data)

   
ZOLL
   
Alsius
   
Adjustment
     
Total
 
                           
Net sales
  $ 398,018     $ 11,330             $ 409,348  
Cost of goods sold
    187,330       8,505     $ 125   (F)     195,960  
Gross profit
    210,688       2,825       125         213,388  
                                   
Expenses:
                                 
Selling and marketing
    111,835       12,897                 124,732  
General and administrative
    30,681       5,711       200   (J)     36,592  
Research and development
    32,398       4,680                 37,078  
Total expenses
    174,914       23,288       200         198,402  
                                   
Income (loss) from operations
    35,774       (20,463 )     (325 )       14,986  
                                   
Investment and other income (expense)
    (258 )     (295 )     295   (G)     (258 )
                                   
Income (loss) before income taxes
    35,516       (20,758 )     (30 )       14,728  
                                   
Provision (benefit) for income taxes
    12,075               (7,276 ) (I)     4,799  
                                   
Net income (loss)
  $ 23,441     $ (20,758 )   $ 7,246       $ 9,929  
                                   
Basic earnings per common share
  $ 1.12                       $ 0.48  
Weighted average common shares outstanding
    20,862                         20,862  
Diluted earnings per common and common equivalent share
  $ 1.10                       $ 0.47  
Weighted average common and common equivalent shares outstanding
    21,304                         21,304  
 
 
Page 5 of 6

 
 
Exhibit 99.2
 
Notes to Unaudited Pro Forma Combined Condensed Financial Statements
 
 
A.
Reflects the $12.2 million in cash paid as consideration for the assets acquired.

 
B.
Reflects the elimination of those assets and liabilities not acquired or assumed as part of the asset acquisition.

 
C.
Represents excess purchase price over fair value of net tangible and intangible assets.

 
D.
Estimated fair value of acquired intangible assets of $3.5 million.

 
E.
Liabilities assumed were limited to the warranty reserve of $77,000 and deferred service contracts of $121,000 which represents the fair market value of the obligation assumed.

 
F.
To record the difference between the book value and the fair value of the finished goods inventory acquired (step-up).

 
G.
Reflects the reversal of interest expense incurred by Alsius related to pre-acquisition debt which was repaid in connection with Alsius' sale of assets. Reflects the reversal of interest income on the cash which was not acquired as part of the asset acquisition.

 
H.
Represents the elimination of Alsius equity.

I.
To adjust income taxes for the Alsius losses and pro forma adjustments utilizing a 35% statutory tax rate.

J.
Represents amortization of the estimated fair value of amortizable intangible assets acquired from Alsius.
 
 
Page 6 of 6